BioPharma rues missed 13% credit as it changes discount control again
High-yielding BioPharma Credit caps the amount the debt fund must spend on share buybacks after having to let a lucrative lending opportunity go because its cash was tied up.
Investment company news brought to you by Citywire Financial Publishers Limited and Quoted Data by Marten & Co.
High-yielding BioPharma Credit caps the amount the debt fund must spend on share buybacks after having to let a lucrative lending opportunity go because its cash was tied up.
Schroder Asian Total Return returns to index-beating form after a difficult 2022, with fund managers Robin Parbrook and Lee King Fuei sidestepping the turmoil in China last year.
Virtually all shareholders vote to wind down Digital 9 Infrastructure whose shares have fallen to a fifth of their flotation price three years ago. Strategic review specialists Brett Miller and Richard Boléat resign shortly after joining the board.
BioPharma Credit (BPCR) announced its annual results for the year ended 31 December 2023. The company saw NAV growth of 1.5% over the period while mai...
Germany-focused business park investor Sirius Real Estate uses £48m of last November’s share issue to expand its UK portfolio.
The Aurora Investment Trust (ARR) announced its annual results for the year ended 31 December 2023. Performance for the year was very positive, with a...
JPMorgan American (JAM) announced its annual results for the period end 31 December 2024. The company generated a NAV total return of 24.7% in 2023 co...
abrdn Asian Income Fund (AAIF) announced its annual results for the year ended 31 December 2023. The company saw a NAV total return of 2.5%, slightly ...
Sirius Real Estate has acquired Vantage Point Business Village, a multi-let business park in Gloucestershire, for £48.25m (€56.4m), representing a net...
BlackRock Latin American Investment Trust (BRLA) announced its annual results for the year ended 31 December 2023. The company’s NAV was up 37.8% in U...
The Fidelity Japan Trust (FJV) has announced its annual results for the year ended 31 December 2023 During the year the trust reported a net asset val...
BioPharma Credit (BPCR) announced its annual results for the year ended December 31 2023. The company saw a NAV return of 1.5% over the period while s...
Developed by Moore-Wilson